Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 12
- Exclusivities
- 2
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 3 |
| Route | NDCs |
|---|---|
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| idorsia pharmaceuticals ltd | 3 |
Exclusivity
Patents and exclusivities
12| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8324232 | TRYVIOaprocitentan | substance, product | Sept 2029 |
| 9732075 | QUVIVIQdaridorexant hydrochloride | substance, product | Jun 2033 |
| 10023560 | QUVIVIQdaridorexant hydrochloride | use | Dec 2034 |
| 9790208 | QUVIVIQdaridorexant hydrochloride | substance, product | Dec 2034 |
| 11174247 | TRYVIOaprocitentan | use | Nov 2037 |
| 10919881 | TRYVIOaprocitentan | substance, product | Feb 2038 |
| 12297189 | TRYVIOaprocitentan | product | Feb 2038 |
| 11787782 | TRYVIOaprocitentan | use | Mar 2038 |
| 11680058 | TRYVIOaprocitentan | use | Jul 2038 |
| Product | Exclusivity | Until |
|---|---|---|
| QUVIVIQDARIDOREXANT HYDROCHLORIDE | M-200 Miscellaneous | Sept 2027 |
| TRYVIOAPROCITENTAN | NCE New chemical entity | Mar 2029 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| QUVIVIQ | Daridorexant | tablet, film coated, oral | 80491-7825NDA |
| QUVIVIQ | Daridorexant | tablet, film coated, oral | 80491-7850NDA |
| TRYVIO | Aprocitentan | tablet, film coated, oral | 80491-8012NDA |
Enquiry
Common questions
- Is Idorsia Pharmaceuticals Ltd FDA approved?
- Idorsia Pharmaceuticals Ltd holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Idorsia Pharmaceuticals Ltd make?
- 3 products are listed under Idorsia Pharmaceuticals Ltd in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.